Roivant Sciences Ltd. (ROIV)
20.14
-0.29
(-1.42%)
USD |
NASDAQ |
Dec 10, 12:29
Roivant Sciences EPS Diluted (Quarterly): -0.1667 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.8065 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Tiziana Life Sciences Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -166.04M |
| Revenue (Quarterly) | 1.571M |
| Total Expenses (Quarterly) | 115.09M |
| Enterprise Value | 10.36B |
| Gross Profit Margin (Quarterly) | 34.31% |
| Profit Margin (Quarterly) | -10.57K% |
| Earnings Yield | -2.74% |
| Normalized Earnings Yield | -3.224 |